Three years ago, the FDA found so many violations at a Nephron Pharmaceuticals manufacturing facility that the U.S. regulator admitted in a warning letter the issues were so numerous they couldn’t all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback